Lerman-Garber I, Rosales-Calderón M

Language: Spanish
References: 26
Page: 312-317
PDF size: 55.91 Kb.

ABSTRACT

Glucose tolerance declines with age, resulting in a high prevalence of type 2 diabetes and impaired glucose tolerance in the elderly population. The pathogenesis of the age-related glucose intolerance is multifactorial; includes the interaction of many variables associated with aging including increased visceral adiposity, decreased physical activity, the use of diverse medications, coexisting illness, diminished insulin secretion and sensitivity, however the age-related effect over glucose metabolism is still controversial. In Mexico glucose intolerance is present in 15-20% of the population older than 60 years and increases the risk for developing diabetes and cardiovascular disease. Patients diagnosed with diabetes at an advanced age have particular characteristics; tend to be less obese, have more β cell dysfunction and may be diagnosed with a hyperosomolar state. Lifestyle modifications are particularly effective in preventing diabetes in this age group.

REFERENCES

1. King HH, Aubert REH. Global Burden of Diabetes, 1995- 2025. Prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-31.

2. Wild S, Bchir M, Roglic G, et al. Global Prevalence of Diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.

3. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination Survey 1988-1994. Diabetes Care 1998; 21: 518-24.

4. Chang AM, Halter JB. Aging and insulin secretion. Am J Physiol Endocrinol Metab 2003; 284: E7-E12.

5. Morley JE. Diabetes and Aging: Epidemiologic Overview. Clin Geriatr Med 2008; 24:395-405.

6. Olaiz G, Rojas R, Barquera S, et al. Encuesta Nacional de Salud 2000. Tomo 2. La salud de los adultos. Cuernavaca, Morelos, México. Instituto Nacional de Salud Pública, 2003.

7. Olaiz-Fernández G, Rivera-Dommarco J, Shamah-Levy T, et al. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, México: Instituto Nacional de Salud Pública, 2006.

8. Kim MJ, Rolland Y, Cepeda O, et al. Diabetes mellitus in older men. Aging Male 2006; 9: 139-47.

9. Resnick HE, Heineman J, Stone R, et al. Diabetes in nursing homes: United States 2004. Diabetes Care 2007; 31: 287-8.

10. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-97.

11. Mazza AD. Insulin Resistance Syndrome and Glucose Dysregulation in the Elderly. Clin Geriatr Med 2008; 24: 437-54.

12. Elahi D, MullerDC. Carbohydrate metabolism in the elderly. European Journal of Clinical Nutrition 200; 54: S112-S120.

13. Muller DC, Elahi D, Tobin JD, et al. Insulin response during the oral glucose tolerance test: the role of age, sex, body fat and the pattern of fat distribution. Aging Clin Esp Res 1996; 8: 13-21.

14. Gracía GV, Freman RV, Supiano MA, et al. Glucose metabolism in older adults: a study including subjects more than 80 years of age. J Am Geriatr Soc 1997; 45: 813-7.

15. Meneilly GS, Ryan AS, Veldhuis JD, et al. Increased disorderliness of basal insulin release, attenuated insulin secretory burst mass, and reduced ultradian rhythmicity of insulin secretion in older individuals. J Clin Endocrinol Metab 1997; 82: 4088-93.

16. Minaker KL, Rowe JW, Tonno R, et al. Influence of age on clearance of insulin in man. Diabetes 1982; 31: 851-5.

17. Meneilly GS, Demuth HU, McIntosh CHS, et al. Effect of aging and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidil peptidase IV responses to oral glucose. Diabet Med 2000; 17: 346-50.

18. Meneilly GS, Elliot T, Tessier D, et al. NIDDM in the elderly. Diabetes Care 1997;19:1320-4.

19. Ferranini E, Vichi S, Beck-Nielsen H, et al. Insulin action and age. Diabetes 1996; 45: 947-53.

20. Lechleitner M. Obesity and the Metabolic Syndrome in the Elderly – A Mini-Review. Gerontology 2008; 54: 253-9.

21. Lowell BB, Schulman GI. Mitochondrial dysfunction and type 2 diabetes. Science 2005; 307: 384-7.

22. Petersen KH, Befroy D, Dufour S, et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003: 300: 1140-2.

23. Mazza AD, Morley JE. Metabolic syndrome and the older male population. Aging Male 2007; 10: 3-8.

24. American Diabetes Association. Position Statement. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2009: 32: S62-S67.

25. Diabetes Prevention Program Research Group. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. N Engl J Med 2002; 346: 393-403.

26. Chiasson JL, Josse RG, Gomis R, et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial. Lancet 2002; 359: 2072-7.